Burgundy Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$212M Sell
3,460,983
-20,455
-0.6% -$1.18M 2% 14
2025
Q2
$205M Buy
3,481,438
+679,691
+24% +$43.9M 2% 11
2025
Q1
$205M Buy
2,801,747
+183,639
+7% +$15.2M 2.13% 8
2024
Q4
$217M Buy
2,618,108
+43,330
+2% +$3.42M 2.19% 11
2024
Q3
$184M Buy
2,574,778
+59,887
+2% +$4.23M 1.82% 16
2024
Q2
$172M Buy
2,514,891
+35,054
+1% +$2.09M 1.82% 17
2024
Q1
$133M Buy
2,479,837
+782,285
+46% +$42.1M 1.37% 29
2023
Q4
$90.5M Buy
1,697,552
+663,782
+64% +$32.4M 1% 41
2023
Q3
$51.3M Buy
1,033,770
+775,615
+300% +$43.4M 0.63% 58
2023
Q2
$15.4M Buy
+258,155
New +$14.7M 0.18% 81

Other funds holding GMED

Burgundy Asset Management's GMED Position: Q3 2025 in Review

Burgundy Asset Management reduced its Globus Medical (GMED) stake by 0.59% in Q3 2025, selling an estimated $1.18M and leaving 3,460,983 shares worth $212M. The position accounts for 2% of the portfolio, ranked #14.

Burgundy Asset Management first reported a position in GMED in Q2 2023 and has held it in 10 quarters since. The position peaked at $217M in Q4 2024. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Burgundy Asset Management held 3,460,983 shares of Globus Medical worth $212M as of Q3 2025.
  • Burgundy Asset Management sold 20,455 Globus Medical shares in Q3 2025, an estimated $1.18M.
  • Globus Medical made up 2% of Burgundy Asset Management's portfolio in Q3 2025, its #14 holding.
  • Burgundy Asset Management first reported a position in Globus Medical in Q2 2023 and has held it in 10 quarters since.
  • Burgundy Asset Management's Globus Medical position peaked at $217M in Q4 2024.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Burgundy Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.